bretylium tosylate has been researched along with cytarabine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Ho, SC; Izumi, H; Michelakis, AM | 1 |
3 other study(ies) available for bretylium tosylate and cytarabine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A comparative study of the effects of cyclocytidine and norepinephrine on renin and esterase release from mouse submandibular gland.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Ancitabine; Animals; Bretylium Tosylate; Cytarabine; Esterases; Histocytochemistry; Male; Mice; Mice, Inbred ICR; Norepinephrine; Renin; Submandibular Gland; Time Factors | 1983 |